Autolus Therapeutics (AUTL)
NASDAQ: AUTL
· Real-Time Price · USD
1.83
-0.05 (-2.66%)
At close: Aug 19, 2025, 9:45 AM
Autolus Therapeutics Revenue
Autolus Therapeutics reported an annual revenue of $10.12M, reflecting a 496% growth. For the quarter ending March 31, 2025, Autolus Therapeutics generated $8.98M in revenue.
Revenue (ttm)
10.12M
Revenue Growth
496%
Price / Sales Ratio
59.25
Revenue / Employee
15.64K
Employees
647
Market Cap
487.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 10.12M | +496.00% |
| Dec 31, 2023 | 1.7M | -72.59% |
| Dec 31, 2022 | 6.19M | +165.84% |
| Dec 31, 2021 | 2.33M | +862.81% |
| Dec 31, 2020 | 242K | -91.68% |
| Dec 31, 2019 | 2.91M | +178.19% |
| Sep 30, 2018 | 1.05M | -38.25% |
| Sep 30, 2017 | 1.69M | +39.69% |
| Sep 30, 2016 | 1.21M | +1187.83% |
| Sep 30, 2015 | 94.11K | n/a |